In vitro production of pregnancy-associated plasma protein A by human decidua and trophoblast.
Immunohistochemical techniques and direct measurements of pregnancy-associated plasma protein A (PAPP-A) have demonstrated the presence of PAPP-A in trophoblast and decidua. The purpose of the present study was to investigate the possibility that these tissues are capable of producing PAPP-A in vitro. Trophoblast and decidua were obtained from term deliveries and from legal surgical terminations of pregnancy (7 to 12 weeks). In addition to trophoblast and decidua, myometrium was also obtained during two hysterectomies in the first trimester of pregnancy. Tissues were incubated in medium 199 at 37 degrees C under an oxygen/carbon dioxide atmosphere. Media containing either pregnancy-associated serum or non-pregnancy-associated serum were changed after 8 hours of incubation in medium 199 alone. In addition to PAPP-A, human placental lactogen (hPL) and prolactin (Prl) were measured in homogenates and media by radioimmunoassays in order to confirm the viability of the cultured tissues. Addition of pregnancy-associated serum to the media induced a significant release of PAPP-A from trophoblast and decidua when compared to that in control cultures. Non-pregnancy-associated serum had no effect. Myometrium did not release any measurable PAPP-A into the medium even in the presence of pregnancy-associated serum. Cycloheximide added to pregnancy-associated serum significantly inhibited the release of PAPP-A from trophoblast and decidua. These last tissues, irrespective of the culture condition, released significantly more PAPP-A as well as hPL and Prl than was initially present in the tissue. These data demonstrate that PAPP-A is released in vitro by trophoblast and decidua (but not by myometrium) and that this release can be magnified by a factor present only in pregnancy-associated serum. The release of PAPP-A, hPL, and Prl is considered as a de novo production since concentration of these proteins are higher in media and tissues after incubation compared to concentrations initially present in the tissue before culture and since cycloheximide significantly inhibits the release of PAPP-A, Prl, and hPL from the cultured tissues.
D003470:Culture Media; D046508:Culture Techniques; D003513:Cycloheximide / Q000494:pharmacology; D003656:Decidua / Q000378:metabolism*; D005260:Female; D006801:Humans; D009215:Myometrium / Q000378:metabolism; D010928:Placental Lactogen / Q000096:biosynthesis; D011257:Pregnancy Proteins / Q000096:biosynthesis*; D011266:Pregnancy-Associated Plasma Protein-A / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D011388:Prolactin / Q000096:biosynthesis; D011863:Radioimmunoassay; D014327:Trophoblasts / Q000378:metabolism*
D003470:Culture Media; D011257:Pregnancy Proteins; D011388:Prolactin; D010928:Placental Lactogen; D003513:Cycloheximide; D011266:Pregnancy-Associated Plasma Protein-A